bunazosin has been researched along with Myocardial Infarction in 2 studies
bunazosin: structure
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether bunazosin (alpha 1-adrenoceptor blocking agent) can alter the hemodynamic profile of chronic heart failure secondary to myocardial infarction, the drug was administered to Wistar rats 4 weeks after coronary ligation, and continued for 4 weeks." | 7.67 | Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure. ( Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T, 1989) |
| "To determine whether bunazosin (alpha 1-adrenoceptor blocking agent) can alter the hemodynamic profile of chronic heart failure secondary to myocardial infarction, the drug was administered to Wistar rats 4 weeks after coronary ligation, and continued for 4 weeks." | 3.67 | Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure. ( Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T, 1989) |
| "Tyramine (Tyr) was intravenously administered before 30 min ischaemia in the absence or presence of bunazosin (BN, alpha1-receptor blocker) and staurosporine (ST), a protein kinase C inhibitor, respectively." | 1.33 | Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits. ( Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, K | 1 |
| Minatoguchi, S | 1 |
| Zhang, C | 1 |
| Kariya, T | 1 |
| Uno, Y | 1 |
| Kawai, T | 1 |
| Takahashi, M | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
| Itagaki, T | 1 |
| Toma, Y | 1 |
| Umemoto, S | 1 |
| Yamakawa, K | 1 |
| Yoshinaga, T | 1 |
| Fukuta, S | 1 |
| Kusukawa, R | 1 |
2 other studies available for bunazosin and Myocardial Infarction
| Article | Year |
|---|---|
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Rec | 2005 |
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; | 1989 |